AstraZeneca COVID-19 vaccine shows promise in elderly, trial results by Christmas
Test results show that a COVID-19 vaccine being developed by AstraZeneca and the University of Oxford can produce a strong immune response in older people. Julian Satterthwaite reports.
UP NEXT
UP NEXT
-
Pandoro Pudding
Australian Women's Weekly
-
Brussel Sprout Salad
Australian Women's Weekly
-
Potato Gnocchi
Australian Women's Weekly
-
Pfizer vaccine appears effective against coronavirus variant found in Britain - study
Reuters
-
European countries struggle to make most of Pfizer COVID-19 vaccine doses
Reuters
-
Supermarket chain Aldi to pay U.S. workers who get COVID-19 vaccination
Reuters
-
Brazil to begin vaccination campaign on Monday afternoon
Reuters
-
Brazil vaccinations start as country faces vaccine ingredient shortfall
Reuters
-
Brazil vaccinations start as country faces vaccine ingredient shortfall
Reuters
-
Vaccine nationalism puts world on brink of 'catastrophic moral failure': WHO chief
Reuters
-
UK says vaccine manufacturing is 'lumpy' but still on course for targets
Reuters
-
'Go for it,' says first person vaccinated in India's massive COVID-19 campaign
Reuters
-
'Go for it,' says first person vaccinated in India's massive COVID-19 campaign
Reuters
-
Vaccine shortages arise across U.S., halting inoculations in some places
Reuters
-
Trump administration accused of deception in pledging release of vaccine stockpile
Reuters
-
Fast-spreading UK coronavirus variant could be dominant in U.S. by March, CDC says
Reuters